Covid-19: a coronavirus update

Covid-19: a coronavirus update

In these difficult times with the Covid-19 (Coronavirus) outbreak, to protect our staff members, the majority of the RD Biomed and Peptest team will be working from home and following all of the government guidelines for the near future. We are temporarily suspending...
Meet Jeanine: our Senior Laboratory Technician

Meet Jeanine: our Senior Laboratory Technician

Let’s introduce you to a key member of the RD Biomed and Peptest team… Jeanine Fisher. Jeanine joined our company in 2006 and can usually be found in the Peptest laboratories at Castle Hill Hospital in Hull. As a Senior Laboratory Technician – and Project...
Peptest celebrates official launch in China

Peptest celebrates official launch in China

Peptest – a non-invasive device for diagnosing reflux disease – has been approved by Chinese health authorities and officially launched in China. The device detects the presence of pepsin (recognised as a diagnostic biomarker for reflux) in saliva samples. Leading...
Second ‘Peptest Day’ in the Czech Republic

Second ‘Peptest Day’ in the Czech Republic

The Peptest team headed to the Czech Republic in October to take part in the second annual ‘Peptest Day’ hosted by Imedex. Imedex, our exclusive distributor for the Czech Republic and Slovakia, organised the knowledge-sharing workshop to coincide with the Pneumology...
Peptest gets ‘approval’ to launch in China

Peptest gets ‘approval’ to launch in China

The Peptest team has headed to China this week to finalise plans for the official launch of our reflux diagnostic device in the world’s most populous country. In an exciting development for Peptest, we’re thrilled to reveal that following years of intensive research,...